Treatment of acquired von willebrand disease due to extracorporeal membrane oxygenation in a pediatric covid-19 patient with vonicog alfa: a case report and literature review

HIGHLIGHTS

  • who: THIEME and collaborators from the University Hospital Carl Gustav Carus at the Technische Universitu00e4t Dresden, Dresden, Germany have published the article: Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review, in the Journal: (JOURNAL) of August/29,/2022

SUMMARY

    Hemorrhagic events are frequently observed in critically ill patients with the need for extracorporeal membrane oxygenation (ECMO) therapy.1,2 A recent large cohort study investigating 210 ECMO patients suggested, that severe bleeding complication is more . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?